These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32970916)

  • 21. NADP modulates RNA m
    Wang L; Song C; Wang N; Li S; Liu Q; Sun Z; Wang K; Yu SC; Yang Q
    Nat Chem Biol; 2020 Dec; 16(12):1394-1402. PubMed ID: 32719557
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dysregulation of USP18/FTO/PYCR1 signaling network promotes bladder cancer development and progression.
    Song W; Yang K; Luo J; Gao Z; Gao Y
    Aging (Albany NY); 2021 Jan; 13(3):3909-3925. PubMed ID: 33461172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FTO: An Emerging Molecular Player in Neuropsychiatric Diseases.
    Annapoorna PK; Iyer H; Parnaik T; Narasimhan H; Bhattacharya A; Kumar A
    Neuroscience; 2019 Oct; 418():15-24. PubMed ID: 31442565
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deciphering the "m
    Garcia-Campos MA; Edelheit S; Toth U; Safra M; Shachar R; Viukov S; Winkler R; Nir R; Lasman L; Brandis A; Hanna JH; Rossmanith W; Schwartz S
    Cell; 2019 Jul; 178(3):731-747.e16. PubMed ID: 31257032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N6-methyladenosine demethyltransferase FTO-mediated autophagy in malignant development of oral squamous cell carcinoma.
    Wang F; Liao Y; Zhang M; Zhu Y; Wang W; Cai H; Liang J; Song F; Hou C; Huang S; Zhang Y; Wang C; Hou J
    Oncogene; 2021 Jun; 40(22):3885-3898. PubMed ID: 33972683
    [TBL] [Abstract][Full Text] [Related]  

  • 26. RNA N6-methyladenosine demethylase FTO promotes breast tumor progression through inhibiting BNIP3.
    Niu Y; Lin Z; Wan A; Chen H; Liang H; Sun L; Wang Y; Li X; Xiong XF; Wei B; Wu X; Wan G
    Mol Cancer; 2019 Mar; 18(1):46. PubMed ID: 30922314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Saikosaponin D exhibits anti-leukemic activity by targeting FTO/m
    Sun K; Du Y; Hou Y; Zhao M; Li J; Du Y; Zhang L; Chen C; Yang H; Yan F; Su R
    Theranostics; 2021; 11(12):5831-5846. PubMed ID: 33897884
    [No Abstract]   [Full Text] [Related]  

  • 28. Reversible RNA adenosine methylation in biological regulation.
    Jia G; Fu Y; He C
    Trends Genet; 2013 Feb; 29(2):108-15. PubMed ID: 23218460
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA N6-methyladenosine demethylase FTO regulates PD-L1 expression in colon cancer cells.
    Tsuruta N; Tsuchihashi K; Ohmura H; Yamaguchi K; Ito M; Ariyama H; Kusaba H; Akashi K; Baba E
    Biochem Biophys Res Commun; 2020 Sep; 530(1):235-239. PubMed ID: 32828292
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Prognostic Implications of Methylated RNA and Demethylases in Resected HCC and Background Liver Tissue.
    Nakagawa N; Tanaka K; Sonohara F; Kandimalla R; Sunagawa Y; Inokawa Y; Takami H; Hayashi M; Yamada S; Kanda M; Tanaka C; Nakayama G; Koike M; Kodera Y
    Anticancer Res; 2020 Dec; 40(12):6665-6676. PubMed ID: 33288560
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The tumor-suppressive effects of alpha-ketoglutarate-dependent dioxygenase FTO via N6-methyladenosine RNA methylation on bladder cancer patients.
    Yi W; Yu Y; Li Y; Yang J; Gao S; Xu L
    Bioengineered; 2021 Dec; 12(1):5323-5333. PubMed ID: 34499008
    [TBL] [Abstract][Full Text] [Related]  

  • 32. FTO, m
    Mauer J; Jaffrey SR
    FEBS Lett; 2018 Jun; 592(12):2012-2022. PubMed ID: 29754392
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N6-methyladenosine(m
    Tang J; Su Q; Guo Z; Zhou J; Zheng F; Yu G; Shao W; Hu H; Wu S; Li H
    Environ Pollut; 2022 Mar; 297():118749. PubMed ID: 34968619
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probing N6-methyladenosine RNA modification status at single nucleotide resolution in mRNA and long noncoding RNA.
    Liu N; Parisien M; Dai Q; Zheng G; He C; Pan T
    RNA; 2013 Dec; 19(12):1848-56. PubMed ID: 24141618
    [TBL] [Abstract][Full Text] [Related]  

  • 35. m
    Huff S; Tiwari SK; Gonzalez GM; Wang Y; Rana TM
    ACS Chem Biol; 2021 Feb; 16(2):324-333. PubMed ID: 33412003
    [No Abstract]   [Full Text] [Related]  

  • 36. RNA N6-methyladenosine demethylase FTO promotes pancreatic cancer progression by inducing the autocrine activity of PDGFC in an m
    Tan Z; Shi S; Xu J; Liu X; Lei Y; Zhang B; Hua J; Meng Q; Wang W; Yu X; Liang C
    Oncogene; 2022 May; 41(20):2860-2872. PubMed ID: 35422475
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The dual role of N6-methyladenosine modification of RNAs is involved in human cancers.
    He L; Li J; Wang X; Ying Y; Xie H; Yan H; Zheng X; Xie L
    J Cell Mol Med; 2018 Oct; 22(10):4630-4639. PubMed ID: 30039919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rolling circle extension-assisted loop-mediated isothermal amplification (Rol-LAMP) method for locus-specific and visible detection of RNA N6-methyladenosine.
    Li J; Zhou J; Xia Y; Rui Y; Yang X; Xie G; Jiang G; Wang H
    Nucleic Acids Res; 2023 May; 51(9):e51. PubMed ID: 36971119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The dynamic epitranscriptome: N6-methyladenosine and gene expression control.
    Meyer KD; Jaffrey SR
    Nat Rev Mol Cell Biol; 2014 May; 15(5):313-26. PubMed ID: 24713629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FTO mediates LINE1 m
    Wei J; Yu X; Yang L; Liu X; Gao B; Huang B; Dou X; Liu J; Zou Z; Cui XL; Zhang LS; Zhao X; Liu Q; He PC; Sepich-Poore C; Zhong N; Liu W; Li Y; Kou X; Zhao Y; Wu Y; Cheng X; Chen C; An Y; Dong X; Wang H; Shu Q; Hao Z; Duan T; He YY; Li X; Gao S; Gao Y; He C
    Science; 2022 May; 376(6596):968-973. PubMed ID: 35511947
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.